Results 231 to 240 of about 1,625,637 (295)

The Value of Interprofessional Continuing Education and Joint Accreditation. [PDF]

J CME
Murry LT, Graebe J, Holderly M, Regnier K, Travlos DV.   +4 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

An adaptive multi-scale spatio-temporal graph network for robust MOOC dropout prediction. [PDF]

Sci Rep
Duan Y, Chen X.
europepmc   +1 more source

An ecological model of vaginal dysbiosis provides new research leads. [PDF]

PLoS Biol
Massol F.
europepmc   +1 more source

Global research trends and hotspots in the health effects of Tai Chi on older adults: a bibliometric analysis (2010-2025). [PDF]

Front Public Health
Niu Y, Zhang Q, Liu Q, Wang M.
europepmc   +1 more source

Big Tau: Structure, Evolutionary Divergence, and Emerging Roles in Cytoskeletal Dynamics and Tauopathies. [PDF]

Cells
Fischer I, Baas PW.
europepmc   +1 more source

Bibliometric mapping of glioma classification research through main path, key route, and K-core analyses. [PDF]

Oncotarget
Ahmed K, N X Fa X F Ez-R X Ed Os JE.
europepmc   +1 more source